When researchers treated GC-C knockout mice with amphetamine-based ADHD medication and an activator of the protein kinase PKG, they reversed the mice’s hyperactive, inattentive behavior.
The study was conducted by the Gastroenterology, Hepatology and Nutrition Department at Cincinnati Children’s Hospital Medical Center and scientists in China.
Read the Cincinnati Children’s Hospital release on linking guanylyl cyclase-C to ADHD.
Related Articles on Intestinal Conditions:
Treatment Uses Parasitic Worms to Fight Crohn’s Disease
Study: P53, PUMA Independently Regulate IEC Apoptosis in Colitis
Study: Probiotic-Derived Protein can Protect Intestinal Cells From Inflammation
